rAvPAL-PEG

recombinant phenylalanine ammonia-lyase enzyme PEGylated · BioMarin Pharmaceutical

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for rAvPAL-PEG, covering 2017-02-01 to 2021-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003) [Phase 2]